LINA CHENG: Open Payments
NPI 1518797463 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,794 in 146 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,037 · 2025 $2,794
Food & beverage: $2,794
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $566 |
| Amgen Inc. | 22 | $351 |
| UCB, Inc. | 16 | $330 |
| Novartis Pharmaceuticals Corporation | 18 | $302 |
| GENZYME CORPORATION | 9 | $216 |
| PFIZER INC. | 14 | $208 |
| AstraZeneca Pharmaceuticals LP | 10 | $182 |
| ANI Pharmaceuticals, Inc. | 5 | $121 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Janssen Biotech, Inc. | 4 | $75 |
Products named: Bimzelx, RINVOQ, COSENTYX, SKYRIZI, KEVZARA, XELJANZ, SAPHNELO, OTEZLA.
Industry payments across KS — which companies pay providers there.
